Aridhia Informatics, the Dundee-based start-up specialising in storing and analysing healthcare information, has struck a strategic partnership with the US's Glencoe Software.

The new affiliation will create products for the international healthcare and life science markets.

Under the terms of the partnership, Aridhia will also make a “major investment” in Seattle-based Glencoe.

The value of the investment was undisclosed, but Aridhia said it will now become a minority stakeholder in Glencoe.

Both Aridhia, which is chaired by Scottish technology entrepreneur David Sibbald, and Glencoe Software are start-ups based on technology developed at the University of Dundee.

Glencoe has developed technology platforms based on open source software used for the analysis of very large scientific image data sets.

The aim of the partnership will be to develop products using real-world clinical, genetic and research information, in anticipation of an increased focus on stratified medicine, personalised therapies and improved patient outcomes in coming years.

Mr Sibbald, who made his name with the sale of his Atlantech software business to Cisco Systems for £115 million in 2000, said: “This will act as an accelerator to link the laboratory to the clinic, and will be focused on disorders such cardio-vascular disease, diabetes and cancers.

“We see this investment as prescient with the real prospect of using individual genetic and imaging information to tailor treatment for individual patients, so-called personalised medicine, which have a real impact in terms of outcomes, therapies and survivability.

“We anticipate it will not only deliver real benefits to patients and health care professionals, but also will deliver economic advantages associated with world-leading, unique research.”